N-substituted piperidine derivatives as serotonin receptor agents

Details for Australian Patent Application No. 2003247615 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Schlienger, Nathalie; Pawlas, Jan; Fejzic, Alma; Andersson, Carl-Magnus; Hansen, Eva Louise

Agent Griffith Hack

Pub. Number AU-B-2003247615

PCT Number PCT/US03/19797

PCT Pub. Number WO2004/000808

Priority 60/391,269 24.06.02 US

Filing date 20 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 9 August 2007

International Classifications

C07D 211/58 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4525 (2006.01)

A61K 31/453 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/5377 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/08 (2006.01) Drugs for genital or sexual disorders

A61P 15/10 (2006.01) Drugs for genital or sexual disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 25/32 (2006.01) Drugs for disorders of the nervous system

A61P 25/34 Drugs for disorders of the nervous system

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/391,269 24.06.02 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003247615

9 August 2007 Application Accepted

  Published as AU-B-2003247615

6 December 2007 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247616-USE OF TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING AN ACTIVE AGENT AND PERMEATION-ENHANCING BASE FOR THE MANUFACTURE OF A MEDICAMENT TO TREAT VARIOUS FORMS OF INFLAMMATORY DERMATOSIS

2003247614-RETROFITTED NON-HALON FIRE SUPPRESSION SYSTEM AND METHOD OF RETROFITTING EXISTING HALON BASED SYSTEMS